Last updated: August 17, 2026

Examiner: KATAKAM, SUDHAKAR

Tech Center 1700 • Art Units: 1621 1627 1654 1658 1671 1674 1676 1799

This examiner grants 75% of resolved cases

Performance Statistics

74.7%

Allow Rate

+9.7% vs TC avg

1,354

Total Applications

+23.6%

Interview Lift

909

Avg Prosecution Days

Based on 1299 resolved cases, 2023–2026

1.7%

§101 Eligibility

13.0%

§102 Novelty

44.6%

§103 Obviousness

25.3%

§112 Clarity

App #	Title	Status	Assignee
18718838	CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES	Non-Final OA	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18259500	HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME	Final Rejection	Eli Lilly and Company
18274980	TREATING DISORDERS ASSOCIATED WITH DYRK1A DYSFUNCTION	Non-Final OA	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
18576518	MULTIPLE DE NOVO DESIGNED PROTEIN BINDING PROTEINS	Non-Final OA	UNIVERSITY OF WASHINGTON

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.